June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
DRY EYE SYNDROME PREVALENCE RATE DURING COVID-19
Author Affiliations & Notes
  • Mashael Al-Namaeh
    Eye Research Center, Wilmington, Delaware, United States
  • Footnotes
    Commercial Relationships   Mashael Al-Namaeh None
  • Footnotes
    Support  ERC 202109001
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 1515 – A0240. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mashael Al-Namaeh; DRY EYE SYNDROME PREVALENCE RATE DURING COVID-19. Invest. Ophthalmol. Vis. Sci. 2022;63(7):1515 – A0240.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Dry Eye Syndrome (DES) has been increased during the pandemic, as a result of wearing masks using electronic devices and working remotely. During COVID-19, we conducted a survey to determine the prevalence of dry eye syndrome.

Methods : This is a cross-sectional study to determine how frequent DES is during COVID-19 in healthy patients in the United States between the ages of 20 and 45. From October 31, 2021, to December 1, 2021, we administered an Ocular Surface Disease Index (OSDI) questionnaire remotely to 40 subjects. The OSDI survey was used to assess DES.

Results : Subjects had a mean age of 29 years old ± SD 14.14 and 23 of them were males (57.5%), and 17 were females (42.5%). Low DES, moderate DES, and severe DES had a prevalence rate of 15%, 77.5 %, and 7.5 %, respectively, according to the OSDI Survey. 50 % are White, 35 % are African Americans, 7.5 % are Asian, and 7.5% are Hispanic. The prevalence of mild DES during COVID is 77.5%, with 64.50 % of males and 35.50% of females.

Conclusions : The prevalence rate of DES during COVID is high which contribute to the fact of wearing the mask, the use of electronic devices and working remotely.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×